The Rock-It Company Expands Fine Art Logistics Capabilities of DIETL Through Acquisition of Several Strategic Infrastructure Services
The Rock-It Company announced today that DIETL has acquired multiple fine art logistics specialists, strengthening its infrastructure and expanding access to specialized services across key U.S. art markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105175923/en/
The Rock-It Company Expands Fine Art Logistics Capabilities of DIETL Through Acquisition of Several Strategic Infrastructure Services
The acquired companies include Delaware Freeport, Delaware National Art Company, Techno Export, and Registrar Technologies. Together, these businesses add depth across fine art storage, handling, packing, crating, installation support, customs brokerage, and technology-enabled logistics services, complementing DIETL’s existing operations.
Delaware Freeport, a provider of high-security, climate-controlled fine art storage, will operate as Delaware Freeport by DIETL, joining DIETL’s portfolio of trusted storage access points for collectors and institutions. As a U.S.-based foreign trade zone and freeport dedicated to fine art, Delaware Freeport provides added flexibility in how high-value works are managed and cared for over time.
Delaware National Art Company will operate as DNA by DIETL, delivering specialized art transportation, custom crating, fine art storage, and exhibition support with climate-controlled care and sustainable solutions for artists, galleries, and institutions.
The remaining acquired companies expand DIETL’s regional reach, technical expertise, and long-term platform capabilities. They will be incorporated into DIETL’s offering over time as part of the company’s continued investment in growth and operational excellence.
“Bringing these specialized businesses into the DIETL organization further strengthens our ability to support the fine art market with precision, care, and expertise,” said Daniel Rosenthal, President and Chief Executive Officer of The Rock-It Company. “We are excited to continue investing in DIETL’s growth and to deepen the services we provide to collectors, galleries, and institutions.”
The acquisition follows DIETL’s recent expansion into the Middle East with the opening of a new fine art storage and logistics facility in Dubai, UAE, supporting the company’s continued global growth in specialized handling, logistics, and storage of fine art and related assets.
ABOUT DIETL
DIETL is a leading provider of fine art and luxury good logistics, delivering specialized freight forwarding, customs brokerage and secure, climate-controlled storage for some of the world’s most valuable and irreplaceable collections. Built on more than three decades of expertise, DIETL is trusted to manage the most complex logistical challenges across the global art market.
With international reach and access, DIETL serves institutions, galleries, auction houses, collectors, and cultural organizations of every scale. The company is committed to operational excellence with a focus on sustainability solutions, offering its clients environmentally responsible packaging and shipping alternatives, and fostering a culture that supports the communities in which it operates.
ABOUT THE ROCK-IT COMPANY
The Rock-It Company (formerly Global Critical Logistics) is a global leader in mission-critical specialty logistics, trusted to move irreplaceable assets and power extraordinary moments across Live Events and Luxury Goods. Built on a 47-year legacy, Rock-It delivers multimodal freight forwarding, event logistics planning, specialized packing and storage, customs and ATA carnet services, insurance, on-site support, and more.
Rock-It manages the logistics behind concert touring, major sporting events, broadcast productions, film and media, corporate events, experiential activations, rapid response and infrastructure, and the transport and protection of fine art, rare automobiles, and other priceless collections. With access across 160+ countries and with more than 10,000 missions each year, Rock-It serves a diverse list of partners including the FIFA World Cup 2026, the Pebble Beach Concours D’Elegance, RM Sotheby’s, leading hypercar OEMs, multiple Olympic committees, leagues and federations, and other leading brands across the globe.
ABOUT CERTAIN ACQUIRED COMPANIES
Delaware Freeport (“DFP”) was founded in 2015 and offers discrete, state-of-the-art, and cost-effective museum-quality fine art storage and highly skilled technical services including condition reporting, installation, viewing, and repacking. It is the only fine-art dedicated Foreign Trade Zone warehouse in the US. Its associate company Delaware National Art Company LLC (“DNA”) was started in 2018 in Clifton, NJ, and provides expert art handling, trucking, and crating services to the NYC region, also linking DFP to the world with its weekly NJ-DE fine art shuttle service. Registrar Technologies LLC was initially created to solve art world logistical problems with customized tech solutions and has been utilized exclusively by DIETL since 2016. Techno Export, Inc. has been providing licensed customs brokerage services for the fine art import and export shipments since 1981.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260105175923/en/
Contacts
Media Contact
Angus Brown
angus.brown@rockitcompany.com
+1 (212) 507-9689
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics8.1.2026 08:30:00 EET | Press release
4Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for 4P004, enabling the expansion of the Phase 2a INFLAM MOTION clinical trial into the United States (US). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107798042/en/ 4Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for 4P004, enabling the expansion of the Phase 2a INFLAM MOTION clinical trial into the United States (US). The U.S. Food and Drug Administration (FDA) approval marks another strategic step in 4MB’s global clinical deployment across
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo ® in France, Denmark, Iceland, Sweden, Finland and Norway8.1.2026 08:30:00 EET | Press release
Organon today announced that it has entered into an agreement with Daiichi Sankyo Europe to commercialize Nilemdo® (bempedoic acid) in France, Denmark, Iceland, Sweden, Finland and Norway. Nilemdo® is a new, first-in-class drug indicated for patients with high cholesterol and cardiovascular disease risk. It provides an alternative treatment for patients that cannot be treated effectively with statins.ii “This collaboration combines Organon’s commercial agility with Daiichi Sankyo’s expertise in cardiovascular innovation to bring Nilemdo® to patients in France, Denmark, Iceland, Sweden, Finland and Norway,” says Thibault Crosnier Leconte, AVP & Managing Director at Organon Northwest Europe. “By offering a new treatment option for patients who cannot tolerate statins, we are helping to close a persistent gap in cardiovascular care—one that disproportionately affects women – whilst reinforcing our mission to deliver impactful treatments for a healthier every day.” Cardiovascular disease i
Azafaros to Present at J.P. Morgan’s 44 th Annual Healthcare Conference8.1.2026 08:00:00 EET | Press release
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that it will present at J.P. Morgan’s 44th Annual Healthcare Conference on Thursday, January 15. The company’s presentation will begin at 9:30 am PT/12:30 am ET/6:30 am CET. The presentation will focus on the company’s lead product, nizubaglustat, a potential treatment for rare lysosomal storage disorders with neurological involvement including GM1/GM2 gangliosidoses and Niemann-Pick type C disease ((NPC). Two pivotal Phase 3 studies investigating nizubaglustat in GM1/GM2 gangliosidoses and NPC are currently enrolling, with data expected in 2027. The studies build on positive data from a robust clinical program including the Phase 2 RAINBOW study and the PRONTO natural history study. The Phase 3 studies are financed following the company’s successful completion of €132 million series B round completed in 1H 2025. About nizubaglust
Prodapt Earns ISO 42001 Certification, the New Global Benchmark for Responsible Enterprise AI8.1.2026 08:00:00 EET | Press release
Prodapt today announced that it has been awarded the ISO 42001 certification, the world’s first and the only global standard for AI Management Systems (AIMS). Marking a significant milestone in its journey, Prodapt is setting a higher benchmark to deliver secure, ethical, and scalable AI for global enterprises. ISO 42001 lays a rigorous framework for governing AI across strategy, technology, and operations. The certification, awarded by an independent accredited body, validates Prodapt’s enterprise-grade AI management framework, including executive-led oversight, strong technology foundations, and disciplined operational processes. These measures ensure AI systems are responsibly designed, deployed, monitored, and evolved throughout their lifecycle. The evaluation emphasizes risk management, ethical AI practices, transparency, and scalability, confirming Prodapt’s ability to proactively identify and mitigate risks while ensuring accountability in AI-driven outcomes. Human-in-the-loop c
Zilch to Acquire Fjord Bank to Kickstart European Expansion8.1.2026 02:40:00 EET | Press release
Zilch, the consumer payments platform powering the future of commerce, today announces it has signed an agreement to acquire AB Fjord Bank, a Lithuania-based bank with approx. $120M in total assets that is authorised and regulated by the Bank of Lithuania and the European Central Bank. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107714872/en/ Zilch to Acquire Fjord Bank to Kickstart European Expansion The acquisition will represent a major strategic milestone for Zilch, providing a European banking licence that will enable the accelerated rollout of its offering across Europe. Zilch will purchase 100% of Fjord Bank and will establish Lithuania as its European headquarters as a consequence of the transaction, using Vilnius as its operational and regulatory platform for expansion across Europe. Launched in 2021, Fjord Bank is a profitable and fully regulated challenger bank, focusing on online consumer lending and saving
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom